MIMP (Mitochondrial Inner Membrane Protein) inhibitors belong to a class of chemical compounds designed to modulate the activity of proteins located in the inner mitochondrial membrane. Mitochondria are vital organelles responsible for various essential cellular processes, including energy production through oxidative phosphorylation. The inner mitochondrial membrane is a critical site for several key protein complexes involved in the electron transport chain and ATP synthesis. MIMP inhibitors are developed to target specific proteins or processes within this membrane, potentially leading to alterations in mitochondrial function and cellular metabolism. The chemical structures of MIMP inhibitors can vary widely, ranging from small molecules to larger compounds. These inhibitors are designed through various approaches, such as high-throughput screening or structure-based design, to selectively interact with the target proteins in the mitochondrial inner membrane.
The discovery and study of MIMP inhibitors offer valuable insights into the complex mitochondrial machinery that governs cellular energy production. By selectively targeting specific proteins or processes within the inner mitochondrial membrane, researchers can investigate their precise role in cellular bioenergetics and mitochondrial function. The use of MIMP inhibitors provides researchers with powerful tools to study the functional consequences of modulating mitochondrial inner membrane proteins. By interfering with specific mitochondrial processes, scientists can explore their impact on cellular health, homeostasis, and potential implications in various physiological and pathological conditions. As the research on MIMP inhibitors progresses, scientists aim to deepen their understanding of mitochondrial biology and the intricate network of protein interactions within the inner membrane. These studies contribute to a broader knowledge of cellular metabolism and may offer new perspectives on mitochondrial dysfunction in various disease contexts.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Oligomycin | 1404-19-9 | sc-203342 sc-203342C | 10 mg 1 g | $146.00 $12250.00 | 18 | |
Oligomycin is an antibiotic that inhibits ATP synthase, an essential protein complex located in the MIMP, leading to mitochondrial dysfunction. | ||||||
Antimycin A | 1397-94-0 | sc-202467 sc-202467A sc-202467B sc-202467C | 5 mg 10 mg 1 g 3 g | $54.00 $62.00 $1642.00 $4600.00 | 51 | |
Antimycin A is an antibiotic that inhibits complex III of the mitochondrial electron transport chain, leading to an accumulation of reactive oxygen species (ROS) and MIMP dysfunction. | ||||||
Rotenone | 83-79-4 | sc-203242 sc-203242A | 1 g 5 g | $89.00 $254.00 | 41 | |
Rotenone is a pesticide that inhibits complex I of the electron transport chain, leading to ROS production and potential MIMP damage. | ||||||
Myxothiazol | 76706-55-3 | sc-507550 | 1 mg | $145.00 | ||
Myxothiazol is another inhibitor of complex III that can affect MIMP function by disrupting the electron transport chain. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $180.00 $726.00 $1055.00 $3350.00 $5200.00 | 23 | |
A769662 is a synthetic compound that directly activates AMPK, leading to the potential inhibition of MIMP activity. | ||||||
(+)-Etomoxir sodium salt | 828934-41-4 | sc-215009 sc-215009A | 5 mg 25 mg | $148.00 $496.00 | 3 | |
Etomoxir is a compound that inhibits carnitine palmitoyltransferase-1 (CPT1), an enzyme responsible for transporting fatty acids into the mitochondria for β-oxidation, thus impacting MIMP function and mitochondrial energy metabolism. | ||||||